Navigation Links
Triggers and treatment of immediate-type allergic reactions

Sudden allergic reactions can be fatal. The most common triggers of such reactions, also known as anaphylaxis, are wasp and bee venoms, legumes (pulses), animal proteins, and analgesics (painkillers). The incidence of anaphylaxis is age-dependent. In the current issue of Deutsches rzteblatt International, Margitta Worm (Berlin) and her co-authors describe the causes and treatment methods for anaphylaxis, based on data from the anaphylaxis registry of the German-speaking countries (Dtsch Arztebl Int 2014; 111: 367�).

Worm and co-authors analyzed the data from the registry, which covers Germany, Austria, and Switzerland, for information on triggers, symptoms, and treatment from 2006 to 2013; they also evaluated data recorded from ADAC air rescue callouts in 2010 and 2011. A total of 4141 persons were affected by anaphylaxis (52.5% female, 47.5% male), 3168 adults and 973 children. Among children, boys were affected more often than girls (640 boys), whereas among adults, women were the more often affected. Most cases (85%) were classified as severity grade II or III. Grade IV reactions, which are very severe, were less frequently reported: 3% of adult cases and 0.9% of pediatric cases. Among children, foods were the most frequent triggers of allergic reactions; among adults, the most frequent triggers were insect venoms. Of these, wasp stings were reported most often (70%), bee stings more rarely (20%).

Analysis of medical emergency cases showed that epinephrine was used to treat only 14.5% of patients in the anaphylaxis registry with grade III reactions and 43.9% of those with grade IV reactions. Of the patients who had to be treated by air rescue personnel, 19% and 78% respectively received epinephrine. Epinephrine was not used often enough, even though it is recommended in the treatment guidelines for reactions from grade II upward.


Contact: Margitta Worm
Deutsches Aerzteblatt International

Page: 1

Related medicine news :

1. Tiny mutation triggers drug resistance for patients with one type of leukemia
2. Toxin from brain cells triggers neuron loss in human ALS model
3. Genetic flaw in males triggers onset of liver cancer, diabetes
4. In animal study, cold turkey withdrawal from drugs triggers mental decline
5. Figuring Out Your Migraine Triggers Is Tricky
6. Migraine triggers tricky to pinpoint
7. Study Questions Importance of Triggers in Setting Off Migraines
8. Top Road Rage Triggers: Cutting In, Weaving
9. Triggers study evaluates regular staff, ICU specialists
10. Chronic cocaine use triggers changes in brains neuron structure
11. Pleasure eating triggers bodys reward system and may stimulate overeating
Post Your Comments:
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology: